Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12503
Title: Effects of Brassica oleracea extract on impaired glucose and lipid homeostasis in high-fat diet-induced obese mice
Authors: Nanna U.
Naowaboot J.
Chularojmontri L.
Tingpej P.
Wattanapitayakul S.
Keywords: acetyl coenzyme A carboxylase
antidiabetic agent
Brassica oleracea extract
cholesterol
fatty acid
fatty acid synthase
glucose
insulin
leptin
plant extract
sterol regulatory element binding protein 1c
triacylglycerol
unclassified drug
animal experiment
animal model
animal tissue
Article
Brassica oleracea
cholesterol blood level
controlled study
diet induced obesity
fatty acid blood level
gene expression
glucose homeostasis
hormone blood level
impaired glucose tolerance
insulin blood level
insulin sensitivity
lipid blood level
lipid diet
lipid homeostasis
lipogenesis
male
mouse
nonhuman
priority journal
treatment duration
triacylglycerol blood level
Issue Date: 2019
Abstract: Objective: To examine the effect of Brassica oleracea extract (BO) on impaired glucose and lipid homeostasis in high-fat diet (HFD)-induced obese mice. Methods: Obesity of ICR mice was induced by feeding a HFD (45 kcal% lard fat) for 16 weeks. During the last 8 weeks of study period, obese mice were additionally administered with BO (100 and 200 mg/kg/day). The metabolic parameters were determined. The gene expressions of hepatic lipogenesis were also studied. Results: After 8 weeks of treatment, BO (100 and 200 mg/kg) significantly reduced hyperglycemia and improved insulin sensitivity (P < 0.05). The serum lipid (total cholesterol, triglyceride, and non-esterified fatty acid) and hepatic triglyceride and non-esterified fatty acid were decreased (P < 0.05). The levels of insulin and leptin in serum were also decreased (P < 0.05). Moreover, the expressions of hepatic lipogenic genes including sterol regulatory element-binding protein 1c, fatty acid synthase, and acetyl-CoA carboxylase were decreased by BO treatment (P < 0.05). Conclusions: These results suggest that BO is a new therapeutic agent for improving the homeostasis of glucose and lipid in HFD-induced obese mice probably by suppression of lipogenic genes in liver tissue. © 2019 Asian Pacific Journal of Tropical Biomedicine Produced by Wolters Kluwer-Medknow.
URI: https://ir.swu.ac.th/jspui/handle/123456789/12503
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061075624&doi=10.4103%2f2221-1691.250859&partnerID=40&md5=e94451058ffd29e9686f6d8b93de9b6f
ISSN: 22211691
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.